Dermazone Launches OTC Contract Manufacturing Division

PharmaManufacturing.com
01/17/2007

Dermazone Solutions, Inc. announced on Jan. 17 the launch of dermaCM, its FDA-registered manufacturing division in St. Petersburg, Fla., offering state-of-the-art contract manufacturing for OTC cosmeceuticals and topical pharmaceuticals, including formulating, private-labeling, manufacturing, packaging and fulfillment services

Dermazone's manufacturing division can facilitate product production for large cosmeceutical and pharmaceutical firms, both domestic and international, who are seeking overflow facilities. dermaCM offers reverse osmosis USP process water, highly skilled and qualified personnel, and flexibility of batch sizes. Access to Dermazone's nanotechnology for custom and private label products is a consideration for companies seeking cutting-edge topical pharmaceuticals and cosmeceuticals.

For information regarding dermaCM, visit http://www.dermacm.com/.